Scientific Working Group Sessions

On demand from 11 June 2021. 09:00 AM CET

 

ELN-EHA SWG for CML: Chronic myeloid leukemia. 

Chair: R Hehlmann (Germany)

• CML and COVID-19 - What do we know in 2021? D Rea (France)
• The new ELN recommendations for treating CML. A Hochhaus (Germany)
• CML and BCR-ABL monitoring: The poster child for molecular monitoring of hematologic neoplasms. N Cross (United Kingdom)
• The CML genomics/HARMONY PLUS project. S Branford (Australia) 

Live Q&A Panel Discussion. 16 June 2021 11:00 AM - 11:45 AM CET. Virtual room 1.

 

Telemedicine in vulnerable older adults with hematological malignancies in the time of COVID-19. SWG: Aging and hematology

Chair: V Goede (Germany)

• Remote telehealth assessment and monitoring in older and vulnerable cancer patients. R Stauder (Austria)
• Bridging hospital care closer to older adults with hematological malignancies amidst COVID-19 pandemic in Madrid: The Spanish experience. R Cordoba (Spain)
• Outcome of older adults with hematological malignancies in Brescia: The Italian experience. G Rossi (Italy)

Live Q&A Panel Discussion. 13 June 2021 3:00 PM - 3:45 PM CET. Virtual room 2.

 

The critically ill patient during the pandemic. SWG: Infections in hematology

Chair: O Cornely (Germany)

• Pharmacokinetic considerations of anti-infective drugs in the ICU: Drug-drug interactions, ECMO, Renal Replacement Therapy. RE Lewis (Italy)
• Fungal superinfections complicating severe COVID-19 in the ICU. M Hoenigl (Austria)
• ICU admission of hematological patients during the pandemic: Who to admit and what’s the prognosis?. P Koehler (Germany)
• EPICOVIDEHA survey: COVID-19 infections in patients with hematological malignancies - Results from EHA-IDWP registry. L Pagano (Italy)

Live Q&A Panel Discussion. 13 June 2021 1:00 PM - 1:45 PM CET. Virtual room 2.